Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
DESCRIPTION The global pneumococcal vaccine market is expected to grow at a CAGR of XX.XX% to reach a total market size of US$XX.XX billion by 2023, increasing from US$XX.XX billion in 2018. Pneumococcal Vaccines are vaccines against pneumococcal diseases which include pneumonia, meningitis, febrile bacteraemia, otitis media, sinusitis, bronchitis and sepsis. Rising prevalence of pneumococcal diseases across the globe is driving the demand for pneumococcal vaccines. According to WHO, pneumococcal vaccine had been introduced in 134 countries by 2016 end and estimated global coverage was about 42%. Advance market commitments contribute to public health funding and help in the development and manufacture of vaccines in the developing countries. Major market players in the global pneumococcal vaccine market are Pfizer, Sanofi, GSK, Merck, AstraZeneca and Baxter International. By Type On the basis of type, pneumococcal vaccine market is segmented as conjugate vaccines and polysaccharide vaccines. Out of these two, conjugate vaccines are more robust as compared to the polysaccharide ones and hence have a significant market share. By Method By method, market segmentation include injection into a muscle and injection under the skin. By Age Group Market segmentation by age group is as follows: 1. Routine vaccination from 2 through 59 months of age 2. Adults 65 years of age or older 3. Persons 2 years of age or older in conditions like disease, infection, implants or any risk. Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
By Geography In terms of geography, global pneumococcal vaccine segmentation includes North America, South America, Europe, Middle East and Africa, and Asia-Pacific. Rising awareness programmes regarding the proper vaccination is driving the market growth in developing and underdeveloped countries.
Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
TABLE OF CONTENTS 1. Introduction 1.1. Market Definition 1.2. Scope of the Study 1.3. Currency 1.4. Assumptions 1.5. Base, and Forecast Years Timeline 2. Research Methodology 2.1. Research Design 2.2. Secondary Sources 2.3. Validation 3. Key Findings of the Study 4. Market Dynamics 4.1. Drivers 4.2. Restraints 4.3. Opportunities and Market Trends 4.4. Market Segmentation 4.5. Porter’s Five Forces Analysis 4.5.1. Bargaining Power of Suppliers 4.5.2. Bargaining Power of Buyers 4.5.3. Threat of New Entrants 4.5.4. Threat of Substitutes 4.5.5. Competitive Rivalry in the Industry 4.6. Industry Value Chain Analysis 4.7. Industry Regulations 5. Global Pneumococcal Vaccine Market Forecast by Type (US$ Billion) 5.1. Introduction 5.2. Conjugate Vaccines 5.3. Polysaccharide Vaccines 6. Global Pneumococcal Vaccine Market Forecast by Method (US$ Billion) 6.1. Introduction Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
6.2. Injection into a muscle 6.3. Injection under the skin 7. Global Pneumococcal Vaccine Market Forecast by Age Group (US$ Billion) 7.1. Introduction 7.2. Routine Vaccination from 2 through 59 months of age 7.3. Adults 65 years of age or older 7.4. Persons 2 years of age or older in conditions like disease, infection, implants or any risk. 8. Global Pneumococcal Vaccine Market Forecast by Geography (US$ Billion) 8.1. Introduction 8.2. North America 8.3. South America 8.4. Europe 8.5. Middle East and Africa (MEA) 8.6. Asia Pacific (APAC) 8.7. ROC (Rest other Countries) 9. Competitive Intelligence 9.1. Market Share Analysis 9.2. Strategies of Key Players 9.3. Recent Investments and Deals 10. Company Profiles 10.1. Pfizer 10.1.1. Overview 10.1.2. Financials 10.1.3. Products and Services 10.1.4. Key Developments 10.2. Sanofi 10.2.1. Overview 10.2.2. Financials 10.2.3. Products and Services 10.2.4. Key Developments 10.3. GSK Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
10.3.1. Overview 10.3.2. Financials 10.3.3. Products and Services 10.3.4. Key Developments 10.4. Merck 10.4.1. Overview 10.4.2. Financials 10.4.3. Products and Services 10.4.4. Key Developments 10.5. AstraZeneca 10.5.1. Overview 10.5.2. Financials 10.5.3. Products and Services 10.5.4. Key Developments 10.6. Baxter International 10.6.1. Overview 10.6.2. Financials 10.6.3. Products and Services 10.6.4. Key Developments List of Tables List of Figures
Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023
TO ORDER OR REQUEST FOR A SAMPLE: Product: Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023 Link:https://www.knowledge-sourcing.com/products/global-pneumococcal-vaccinemarket-industry-trends-opportunities-and-forecasts-to-2023 Price: US$3,600 – Single User License US$4,600 – Multi User License US$6,600 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment For wire transfer, write to us at sales@knowledge-sourcing.com
For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-866-714-4587
Global Pneumococcal Vaccine Market - Industry Trends, Opportunities and Forecasts to 2023